Home > Income Statement > GUJARAT THEMIS BIOSYN

GUJARAT THEMIS BIOSYN
Revenue

    Back to Income Statement
GUJARAT THEMIS BIOSYN is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
AD     Remove this Ad

GUJARAT THEMIS BIOSYN Last 5 Year Revenue History

[Standalone]

Mar2025Mar2024Mar2023Mar2022Mar2021
Net Sales ₹151 Cr₹170 Cr₹148 Cr₹115 Cr₹91 Cr

What is the latest Revenue of GUJARAT THEMIS BIOSYN ?

The latest Revenue ratio of GUJARAT THEMIS BIOSYN is ₹151 Cr based on Mar2025 Standalone results.
Year Revenue
Mar2025₹151 Cr
Mar2024₹170 Cr
Mar2023₹148 Cr
Mar2022₹115 Cr
Mar2021₹91 Cr

How is Revenue of GUJARAT THEMIS BIOSYN Trending?

Years Revenue % Change
Mar2025 ₹151 Cr
-11.20
Mar2024 ₹170 Cr
14.45
Mar2023 ₹148 Cr
29.19
Mar2022 ₹115 Cr
26.82
Mar2021 ₹91 Cr -

Compare Revenue of peers of GUJARAT THEMIS BIOSYN

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GUJARAT THEMIS BIOSYN ₹3,648.2 Cr 5.8% 6% 45.9% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹415,613.0 Cr 0.9% 6.2% 0.6% Stock Analytics
DIVIS LABORATORIES ₹167,105.0 Cr 1.8% 4.8% 6.3% Stock Analytics
TORRENT PHARMACEUTICALS ₹145,926.0 Cr 1.3% 9.8% 37.7% Stock Analytics
DR REDDYS LABORATORIES ₹109,088.0 Cr 1.7% 5.8% 6.7% Stock Analytics
CIPLA ₹107,120.0 Cr -1.3% 0.9% -8.9% Stock Analytics


GUJARAT THEMIS BIOSYN Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
GUJARAT THEMIS BIOSYN

5.8%

6%

45.9%

SENSEX

0%

1.2%

9.7%


You may also like the below Video Courses